Nuwellis (CHFS) Competitors

Nuwellis (NASDAQ:CHFS) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings, valuation and community ranking.

Do insiders and institutionals hold more shares of CHFS or IRIX?

65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by insiders. Comparatively, 7.3% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has better valuation and earnings, CHFS or IRIX?

IRIDEX has higher revenue and earnings than Nuwellis. IRIDEX is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuwellis	$5.51M	1.05	-$18.11M	-$279.28	0.00
IRIDEX	$48.43M	0.33	-$9.57M	-$0.54	-1.76

Does the media favor CHFS or IRIX?

In the previous week, IRIDEX had 4 more articles in the media than Nuwellis. MarketBeat recorded 5 mentions for IRIDEX and 1 mentions for Nuwellis. IRIDEX's average media sentiment score of 0.25 beat Nuwellis' score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuwellis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility & risk, CHFS or IRIX?

Nuwellis has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.

Does the MarketBeat Community favor CHFS or IRIX?

Nuwellis received 52 more outperform votes than IRIDEX when rated by MarketBeat users. Likewise, 69.53% of users gave Nuwellis an outperform vote while only 62.96% of users gave IRIDEX an outperform vote.

Company	Underperform	Outperform
Nuwellis	Outperform Votes 324 69.53%	Underperform Votes 142 30.47%
IRIDEX	Outperform Votes 272 62.96%	Underperform Votes 160 37.04%

Is CHFS or IRIX more profitable?

IRIDEX has a net margin of -22.79% compared to Nuwellis' net margin of -254.26%. Nuwellis' return on equity of -173.61% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nuwellis	-254.26%	-173.61%	-131.01%
IRIDEX	-22.79%	-192.95%	-33.97%

Do analysts rate CHFS or IRIX?

IRIDEX has a consensus price target of $2.00, indicating a potential upside of 110.53%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Nuwellis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuwellis	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
IRIDEX	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

IRIDEX beats Nuwellis on 10 of the 17 factors compared between the two stocks.